BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35753280)

  • 21. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
    Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
    Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis.
    Ballard AM; Falk D; Greenwood H; Gugerty P; Feinberg J; Friedmann PD; Go VF; Jenkins WD; Korthuis PT; Miller WC; Pho MT; Seal DW; Smith GS; Stopka TJ; Westergaard RP; Zule WA; Young AM; Cooper HLF
    Harm Reduct J; 2023 Oct; 20(1):157. PubMed ID: 37880724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.
    Lancaster KE; Cooper HLF; Browning CR; Malvestutto CD; Bridges JFP; Young AM
    Subst Use Misuse; 2020; 55(14):2268-2277. PubMed ID: 32748730
    [No Abstract]   [Full Text] [Related]  

  • 24. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys.
    Salow K; Jack HE; Tinsley J; Banta-Green CJ; Kingston S; Iles-Shih M; Tsui JI; Glick S
    Harm Reduct J; 2023 Sep; 20(1):133. PubMed ID: 37704989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
    Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
    Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for loss to follow-up of persons who inject drugs enrolled at syringe services programs in Kentucky.
    Soria J; Johnson T; Collins J; Corby-Lee G; Thacker J; White C; Hoven A; Thornton A
    Int J Drug Policy; 2021 Sep; 95():103255. PubMed ID: 33853033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
    Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
    Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consider the Source: Associations between Syringe Sources and Risky Injection Behaviors in California's Central Valley.
    Pollini RA; Ozga JE; Blanchard D; Syvertsen JL
    Subst Use Misuse; 2021; 56(13):2007-2016. PubMed ID: 34379030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky: The central role of staff champions.
    Cooper HLF; Gross S; Klein E; Fadanelli M; Ballard A; Lockard S; Batty E; Young A; Ibragimov U
    Drug Alcohol Rev; 2022 May; 41(4):863-872. PubMed ID: 35112747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.
    Bixler D; Corby-Lee G; Proescholdbell S; Ramirez T; Kilkenny ME; LaRocco M; Childs R; Brumage MR; Settle AD; Teshale EH; Asher A
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(18):529-532. PubMed ID: 29746453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.
    Goedel WC; King MRF; Lurie MN; Galea S; Townsend JP; Galvani AP; Friedman SR; Marshall BDL
    Clin Infect Dis; 2020 Mar; 70(6):1096-1102. PubMed ID: 31143944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
    Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE
    J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
    Syvertsen JL; Pollini RA
    Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 23 Metropolitan Statistical Areas, United States, 2018.
    Handanagic S; Finlayson T; Burnett JC; Broz D; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(42):1459-1465. PubMed ID: 34673746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Funding and Delivery of Syringe Services Programs in the United States, 2022.
    Facente SN; Humphrey JL; Akiba C; Patel SV; Wenger LD; Tookes H; Bluthenthal RN; LaKosky P; Prohaska S; Morris T; Kral AH; Lambdin BH
    Am J Public Health; 2024 Apr; 114(4):435-443. PubMed ID: 38478864
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.
    Surratt HL; Otachi JK; Williams T; Gulley J; Lockard AS; Rains R
    J Rural Health; 2020 Mar; 36(2):224-233. PubMed ID: 31415716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.